PuraMed BioScience, Inc. to Launch E-Commerce Website for Online Purchases of Its...

PuraMed BioScience, Inc. to Launch E-Commerce Website for Online Purchases of
Its Non-Prescription Migraine Treatment LipiGesic(TM) M

SCHOFIELD, Wis., Nov. 4, 2009 (GLOBE NEWSWIRE) -- PuraMed BioScience
(OTCBB:PMBS), announced today it has accelerated the construction of its
e-commerce website due to the volume of calls coming into PuraMed's headquarters
inquiring when the Company's migraine headache treatment LipiGesic(TM) M, will
become available for purchase. The site is expected to launch mid November 2009
and will include innovative brand images and messages with fully functional
e-commerce capability. The site can be found at www.LipiGesic.com. The company
will also promote several URLs that will redirect to the main LipiGesic.com
website, including the vanity site www.mymigrainegone.com and
www.LipiGesicM.com.

Russ Mitchell, PuraMed BioScience President and CEO stated, "We have been
working diligently to complete production of our first direct response
television commercial and our e-commerce offering. As we continue to finalize
production and identify the best airing times available for our commercial, we
believe that providing this e-commerce site will allow us to help migraine
sufferers who have already heard about the product and help others discover a
new, more effective and affordable option to alleviate their migraine pain."

Mitchell continued, "LipiGesic.com will be the 'online storefront' and visual
representation of our products for consumers, and also a main resource for
information on migraine headaches. We believe our new website will greatly
support our efforts and begin generating revenue as we move ahead with
developments for the launch of our products."

About the Company:

PuraMed BioScience, Inc. engages in the research, development and marketing of
non-prescription medicinal and healthcare products. In addition to its leading
product LipiGesic(TM) M, which provides acute relief from migraine headaches;
the Company also has plans to launch LipiGesic(TM) PM that provides a remedy for
insomnia and other sleep disorders as well as LipiGesic(TM) H for common tension
headaches. For more information on PuraMed, visit the Company website at
www.PuraMedBioScience.com, join the Company's group page on Facebook by
searching "PuraMed BioScience" and follow the Company on Twitter at
www.twitter.com/puramed.

Forward Looking Statements:

This news release contains forward-looking statements regarding PuraMed
BioScience and its future business plans, which statements involve known and
unknown risks and uncertainties. Such risks and uncertainties may cause actual
results and future achievements of PuraMed BioScience to be materially different
than those implied by these forward-looking statements. PuraMed BioScience has
and undertakes no obligation to provide public updates and revisions to these
forward-looking statements to reflect any changes in its expectations of future
events.

-0-
CONTACT: PuraMed BioScience, Inc.
Russell Mitchell, Chairman and CEO
715-359-6373
rmitchell@PuramedBioScience.com
Website: www.PuramedBioScience.com

Investor Awareness, Inc.
Investor Relations:
Tony Schor
James Foy
847-945-2222
Website: www.investorawareness.com

North Shore Public Relations, Inc.
Media Contact:
Renae Placinski
847-945-4505
Renae@northshorepr.com
Website: www.northshorepr.com